Literature DB >> 15963159

A survey of health care practitioners' knowledge of the QT interval.

Sana M Al-Khatib1, Nancy M Allen LaPointe, Judith M Kramer, Anita Y Chen, Bradley G Hammill, Liz Delong, Robert M Califf.   

Abstract

OBJECTIVE: To assess health care practitioners' ability to correctly measure the QT interval, and to identify factors and medications that may increase the risk of QT-interval prolongation and torsades de pointes.
DESIGN: A cross-sectional analysis of a survey administered between April 2002 and March 2003. PARTICIPANTS AND
SETTING: Health care practitioners attending Grand Rounds Conferences at 6 academic institutions in the United States in internal medicine and psychiatry and at 6 community hospitals in the same geographical areas as the academic institutions. INTERVENTION: Anonymous, self-administered questionnaire that included 20 questions on the QT interval.
MEASUREMENTS AND MAIN RESULTS: Of approximately 826 attendees, 517 (63%) completed the survey. Of about 608 attendees of internal medicine conferences, 371 (61%) responded, and of about 208 attendees of psychiatry conferences, 146 (67%) responded. Of a total number of 20 questions, the median number of correct answers for the whole group was 10 (interquartile range 7-13). The median number of correct answers for internists was 12 (interquartile range 9-13), for psychiatrists 10 (interquartile range 7-13), and for other specialists 10 (interquartile range 5-13). Respondents who graduated between 1990 and 1999 and academicians performed significantly better overall than other respondents. Of the 517 respondents, 224 (43%) measured the QT interval correctly. Physicians in training and academicians were more likely to measure the QT interval correctly.
CONCLUSION: The majority of health care practitioners cannot correctly measure the QT interval and cannot correctly identify factors and medications that can prolong the QT interval. Our findings suggest that greater attention to the QT interval is warranted to ensure safer use of QT prolonging medications.

Entities:  

Mesh:

Year:  2005        PMID: 15963159      PMCID: PMC1490115          DOI: 10.1111/j.1525-1497.2005.0101.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

1.  A case of severe ischemia-induced QT prolongation.

Authors:  A G Rebeiz; S M Al-Khatib
Journal:  Clin Cardiol       Date:  2001-11       Impact factor: 2.882

Review 2.  Clinical and therapeutic aspects of congenital and acquired long QT syndrome.

Authors:  Ijaz A Khan
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

3.  Knowledge deficits related to the QT interval could affect patient safety.

Authors:  Nancy M Allen LaPointe; Sana M Al-Khatib; Judith M Kramer; Robert M Califf
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

4.  QT interval in patients with unstable angina and non-Q wave myocardial infarction.

Authors:  Vladimir Rukshin; Daniel Monakier; Karen Olshtain-Pops; Jonathan Balkin; Dan Tzivoni
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

Review 5.  What clinicians should know about the QT interval.

Authors:  Sana M Al-Khatib; Nancy M Allen LaPointe; Judith M Kramer; Robert M Califf
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

Review 6.  Mechanisms and management of proarrhythmia.

Authors:  D M Roden
Journal:  Am J Cardiol       Date:  1998-08-20       Impact factor: 2.778

Review 7.  The long QT syndromes: genetic basis and clinical implications.

Authors:  C E Chiang; D M Roden
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

8.  Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.

Authors:  Arthur J Moss; Wojciech Zareba; Elizabeth S Kaufman; Eric Gartman; Derick R Peterson; Jesaia Benhorin; Jeffrey A Towbin; Mark T Keating; Silvia G Priori; Peter J Schwartz; G Michael Vincent; Jennifer L Robinson; Mark L Andrews; Changyong Feng; W Jackson Hall; Aharon Medina; Li Zhang; Zhiqing Wang
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

9.  QT interval prolongation in acute myocardial infarction.

Authors:  S Ahnve
Journal:  Eur Heart J       Date:  1985-11       Impact factor: 29.983

10.  Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.

Authors:  G N Kay; V J Plumb; J G Arciniegas; R W Henthorn; A L Waldo
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

View more
  10 in total

1.  Medical education and JGIM.

Authors:  Brent C Williams
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

2.  Methodology of QT-interval measurement in the modular ECG analysis system (MEANS).

Authors:  Jan A Kors; Gerard van Herpen
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

Review 3.  Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.

Authors:  Arsen Uvelin; Jasmina Pejaković; Vesna Mijatović
Journal:  J Anesth       Date:  2017-02-22       Impact factor: 2.078

4.  A twist on torsade: a prolonged QT interval on methadone.

Authors:  Patricia Lamont; Susan C Hunt
Journal:  J Gen Intern Med       Date:  2006-11       Impact factor: 5.128

Review 5.  Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review.

Authors:  Simone Skullbacka; Marja Airaksinen; Juha Puustinen; Terhi Toivo
Journal:  Eur J Clin Pharmacol       Date:  2022-02-14       Impact factor: 2.953

Review 6.  A literature-based algorithm for the assessment, management, and monitoring of drug-induced QTc prolongation in the psychiatric population.

Authors:  M Zolezzi; L Cheung
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-24       Impact factor: 2.570

7.  Identification of Risk of QT Prolongation by Pharmacists When Conducting Medication Reviews in Residential Aged Care Settings: A Missed Opportunity?

Authors:  Louise Christensen; J Rick Turner; Gregory M Peterson; Mark Naunton; Jackson Thomas; Kwang Choon Yee; Sam Kosari
Journal:  J Clin Med       Date:  2019-11-04       Impact factor: 4.241

8.  Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease.

Authors:  Magdalene M Assimon; Lily Wang; Patrick H Pun; Wolfgang C Winkelmayer; Jennifer E Flythe
Journal:  J Am Heart Assoc       Date:  2020-06-24       Impact factor: 5.501

Review 9.  Survey concerning internal medicine physicians and prolonged QT interval: Knowledge and treatment practices.

Authors:  Elizabeth Wendl; Nelson Telles; Geoff C Wall
Journal:  World J Cardiol       Date:  2021-03-26

10.  Content Validation of an Algorithm for the Assessment, Management and Monitoring of Drug-Induced QTc Prolongation in the Psychiatric Population.

Authors:  Monica Zolezzi; Athar Elhakim; Waad M Elamin; Shorouk Homs; Doaa E Mahmoud; Iman A Qubaiah
Journal:  Neuropsychiatr Dis Treat       Date:  2021-11-19       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.